Nurix Therapeutics shares owned by Duquesne Family Office
Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Duquesne Family Office
from 13F filings
Historical chart of Duquesne Family Office investment in Nurix Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Nurix Therapeutics held by Duquesne Family Office consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Nurix Therapeutics by Duquesne Family Office
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $650k | 44k | 14.71 |